We’ve developed robust algorithms that allow us to generate the most optimal TAL effector designs. Your choice of targets is practically unlimited. The predictability with which Invitrogen TAL effectors bind to exact DNA sequences makes it possible to target any sequence in the genome. From designing, synthesizing and validating your TALEN, we offer end-to-end services to support every step in genome editing. &
Thermo Fisher Scientific is currently the only provider of TALEN technology products and services that includes rights under foundational TAL IP invented at Martin-Luther-University Halle-Wittenberg, the University of Minnesota, and Iowa State University.
The choice of the effector domain determines whether the TAL effector edits or activates the targeted gene. TAL effectors are supplied as mRNA. Choose from a number of services to customize your genome engineering project.
 | |
|---|---|
| 可选规格 | TAL FOKI Endonuclease |
| Recommended format based on application | KO, deletion, and KI |
| Deliverable format | in-vitro transcribed mRNA |
| Compatible transfection reagent | MessengerMax or Neon |
Based on our experience, we recommend that you design and test at least 3 TAL effector pairs and choose the design that provides you with the highest efficiency and minimal off-target effects. We therefore offer a validation service where we design and test at least 3 sequence variations and provide you with the best performing TAL pair.
Discover how our off-the-shelf product portfolio and outsourced services can meet your needs. Contact our dedicated technical support team with any questions, or get started on your services project today:
仅供科研使用，不可用于诊断目的。
